These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23752738)

  • 1. Functional characterization of 32 CYP2C9 allelic variants.
    Niinuma Y; Saito T; Takahashi M; Tsukada C; Ito M; Hirasawa N; Hiratsuka M
    Pharmacogenomics J; 2014 Apr; 14(2):107-14. PubMed ID: 23752738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of a novel CYP2C9 allelic variant in a warfarin-sensitive patient.
    Dai DP; Li CB; Wang SH; Cai J; Geng PW; Zhou YF; Hu GX; Cai JP
    Pharmacogenomics; 2015; 16(13):1475-86. PubMed ID: 26255664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of CYP2C9 genetic polymorphism on the metabolism of flurbiprofen in vitro.
    Wang L; Bao SH; Pan PP; Xia MM; Chen MC; Liang BQ; Dai DP; Cai JP; Hu GX
    Drug Dev Ind Pharm; 2015; 41(8):1363-7. PubMed ID: 25144335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism.
    Sullivan-Klose TH; Ghanayem BI; Bell DA; Zhang ZY; Kaminsky LS; Shenfield GM; Miners JO; Birkett DJ; Goldstein JA
    Pharmacogenetics; 1996 Aug; 6(4):341-9. PubMed ID: 8873220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelic variants of human cytochrome P450 2C9: baculovirus-mediated expression, purification, structural characterization, substrate stereoselectivity, and prochiral selectivity of the wild-type and I359L mutant forms.
    Haining RL; Hunter AP; Veronese ME; Trager WF; Rettie AE
    Arch Biochem Biophys; 1996 Sep; 333(2):447-58. PubMed ID: 8809086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo characterization of 13 CYP2C9 allelic variants found in Chinese Han population.
    Hu GX; Pan PP; Wang ZS; Yang LP; Dai DP; Wang SH; Zhu GH; Qiu XJ; Xu T; Luo J; Lian QQ; Ge RS; Cai JP
    Drug Metab Dispos; 2015 Apr; 43(4):561-9. PubMed ID: 25614704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Assessment of 12 Rare Allelic
    Kumondai M; Ito A; Gutiérrez Rico EM; Hishinuma E; Ueda A; Saito S; Nakayoshi T; Oda A; Tadaka S; Kinoshita K; Maekawa M; Mano N; Hirasawa N; Hiratsuka M
    J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33540768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An identification and functional evaluation of a novel CYP2C9 variant CYP2C9*62.
    Chen H; Dai DP; Zhou S; Liu J; Wang SH; Wu HL; Zhou Q; Geng PW; Chong J; Lü Y; Cai JP; Yang JF
    Chem Biol Interact; 2020 Aug; 327():109168. PubMed ID: 32531309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of novel allelic variants of CYP2C9 recently discovered in southeast Asians.
    DeLozier TC; Lee SC; Coulter SJ; Goh BC; Goldstein JA
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1085-90. PubMed ID: 16099926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro functional characterization of 37 CYP2C9 allelic isoforms found in Chinese Han population.
    Dai DP; Wang YH; Wang SH; Geng PW; Hu LM; Hu GX; Cai JP
    Acta Pharmacol Sin; 2013 Nov; 34(11):1449-56. PubMed ID: 24077631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Characterization of Human CYP2C9 Allelic Variants in COS-7 Cells.
    Du H; Wei Z; Yan Y; Xiong Y; Zhang X; Shen L; Ruan Y; Wu X; Xu Q; He L; Qin S
    Front Pharmacol; 2016; 7():98. PubMed ID: 27199745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of 17 CYP2D6 allelic variants (CYP2D6.2, 10, 14A-B, 18, 27, 36, 39, 47-51, 53-55, and 57).
    Sakuyama K; Sasaki T; Ujiie S; Obata K; Mizugaki M; Ishikawa M; Hiratsuka M
    Drug Metab Dispos; 2008 Dec; 36(12):2460-7. PubMed ID: 18784265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and Functional Assessment of a New CYP2C9 Allelic Variant CYP2C9*59.
    Dai DP; Wang SH; Li CB; Geng PW; Cai J; Wang H; Hu GX; Cai JP
    Drug Metab Dispos; 2015 Aug; 43(8):1246-9. PubMed ID: 25994031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular functionality of CYP2C9 polymorphisms and their influence on drug therapy.
    Jarrar YB; Lee SJ
    Drug Metabol Drug Interact; 2014; 29(4):211-20. PubMed ID: 24825094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterologous Expression and Functional Characterization of Novel CYP2C9 Variants Identified in the Alaska Native People.
    McDonald MG; Henderson LM; Ray S; Yeung CK; Johnson AL; Kowalski JP; Hanenberg H; Wiek C; Thummel KE; Rettie AE
    J Pharmacol Exp Ther; 2020 Aug; 374(2):233-240. PubMed ID: 32423989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of the defective CYP2C9 variant CYP2C9*18.
    Liu J; Chen H; Wang SH; Zhou Q; Geng PW; Zhou YF; Wu HL; Shi HF; Wang F; Yang JF; Cai JP; Dai DP
    Pharmacol Res Perspect; 2021 Feb; 9(1):e00718. PubMed ID: 33508175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalytic activities of human cytochrome P450 2C9*1, 2C9*3 and 2C9*13.
    Guo Y; Wang Y; Si D; Fawcett PJ; Zhong D; Zhou H
    Xenobiotica; 2005 Sep; 35(9):853-61. PubMed ID: 16308280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High warfarin sensitivity in carriers of CYP2C9*35 is determined by the impaired interaction with P450 oxidoreductase.
    Lee MY; Borgiani P; Johansson I; Oteri F; Mkrtchian S; Falconi M; Ingelman-Sundberg M
    Pharmacogenomics J; 2014 Aug; 14(4):343-9. PubMed ID: 24322786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a novel CYP2C9 mutation (1009C>A) detected in a warfarin-sensitive patient.
    Luo SB; Li CB; Dai DP; Wang SH; Wang ZH; Geng PW; Cai J; Jiang ZL; Pu CW; Shang K; Yuan XM; Cao YP; Hu GX; Cai JP
    J Pharmacol Sci; 2014; 125(2):150-6. PubMed ID: 25075423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional Measurement of CYP2C9 and CYP3A4 Allelic Polymorphism on Sildenafil Metabolism.
    Tang PF; Zheng X; Hu XX; Yang CC; Chen Z; Qian JC; Cai JP; Hu GX
    Drug Des Devel Ther; 2020; 14():5129-5141. PubMed ID: 33262574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.